Dendrogenin A Enhances Anti-Leukemic Effect of Anthracycline in Acute Myeloid Leukemia

SIMPLE SUMMARY: Recently, several molecules have improved the clinical outcome of acute myeloid leukemia (AML) patients. Despite these recent advances, their prognosis remains poor and new strategies to improve the standard anthracycline and Ara-C-based chemotherapy are needed. We recently published...

Descripción completa

Detalles Bibliográficos
Autores principales: Mouchel, Pierre-Luc, Serhan, Nizar, Betous, Rémy, Farge, Thomas, Saland, Estelle, De Medina, Philippe, Hoffmann, Jean-Sébastien, Sarry, Jean-Emmanuel, Poirot, Marc, Silvente-Poirot, Sandrine, Récher, Christian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7601603/
https://www.ncbi.nlm.nih.gov/pubmed/33053669
http://dx.doi.org/10.3390/cancers12102933

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7601603/
https://www.ncbi.nlm.nih.gov/pubmed/33053669
http://dx.doi.org/10.3390/cancers12102933

Ejemplares similares